Cargando…
Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
One of the key features of hepatocellular carcinoma (HCC) is the high rate of intrahepatic recurrence that correlates with poor prognosis. Therefore, in order to improve the clinical outcome for patients with HCC, development of a chemopreventive agent that can decrease or delay the incidence of rec...
Autores principales: | Shimizu, Masahito, Shirakami, Yohei, Imai, Kenji, Takai, Koji, Moriwaki, Hisataka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515920/ https://www.ncbi.nlm.nih.gov/pubmed/23230390 http://dx.doi.org/10.4103/1477-3163.100398 |
Ejemplares similares
-
The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells
por: Qin, Xian-Yang, et al.
Publicado: (2013) -
Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells
por: Baba, Atsushi, et al.
Publicado: (2013) -
Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid
por: Qin, Xian-Yang, et al.
Publicado: (2018) -
The phosphorylated retinoid X receptor-α promotes diethylnitrosamine-induced hepatocarcinogenesis in mice through the activation of β-catenin signaling pathway
por: Sakai, Hiroyasu, et al.
Publicado: (2021) -
Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
por: Shimizu, Masahito, et al.
Publicado: (2008)